Biosergen AB (publ) (STO:BIOSGN)
Sweden
· Delayed Price · Currency is SEK 37.00
-1.00 (-2.63%)
Mar 9, 2026, 2:38 PM CET
Biosergen AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
86.88M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Scandinavian ChemoTech AB | 12.29M |
| Biovica International AB | 9.89M |
| OncoZenge AB | 2.78M |
| Alligator Bioscience AB | 4.42M |
| Spago Nanomedical AB | 4.82M |
| Xbrane Biopharma AB | 152.35M |
| Alzinova AB | 26.12M |
| IRLAB Therapeutics AB | 57.46M |